Latest Product Launches News

Zip Co reported a 41.5% jump in third quarter cash EBTDA to $65.1 million, driven by accelerated US transaction volume growth of 43.1% and steady credit losses. The company upgraded its FY26 cash EBTDA guidance to at least $260 million, highlighting robust profitability and expanding customer engagement.

Netwealth delivered a resilient March quarter with $4 billion in net inflows, pushing total funds under administration to $125.8 billion despite a 3.7% market dip. Growth in Managed Accounts and new intermediary relationships underpin ongoing momentum.

Audeara has locked in exclusive Australian rights to a customised assistive listening device from ShokzHear, aiming to tackle widespread listening challenges among schoolchildren through government-backed programs.

Freelancer Limited has delivered a landmark FY25 with record profitability, a major NASA contract win, and significant AI-driven growth across its marketplaces and payment services.

Atomos Limited is acquiring Flanders Scientific to deepen its foothold in professional reference monitors, funded by a new $10 million CBA loan. The deal is immediately earnings accretive and broadens Atomos’ video production ecosystem.

Atomos Limited has obtained a new $10 million finance facility from Commonwealth Bank of Australia to support strategic growth initiatives and product development, while also reducing the cost of its existing loan. The company reconfirms its FY26 revenue and EBITDA guidance despite ongoing global uncertainties.

SPC Global Holdings Limited reported continued improvement in Q3 FY26, with net sales revenue and normalised EBITDA on track to meet full-year guidance. The company is progressing with its Mill Park facility closure and expanding its international footprint, particularly in Asia.

Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.

Latrobe Magnesium has locked in a US$2 million non-dilutive prepayment from its US distribution partner to accelerate commissioning of its Demonstration Plant, aiming for first magnesium deliveries in late 2026.

Botanix Pharmaceuticals has successfully renegotiated its API supply agreement, deferring significant purchases to later years and strengthening its financial position ahead of Sofdra's market rollout.

OMG Group has reported a robust 53% increase in net sales for the first two months of FY26, driven by strong growth across retail and ecommerce channels. The company plans a strategic refresh of its Blue Dinosaur product range to maintain momentum.

Eve Health Group is advancing its proprietary reformulation platform with two fast-onset products launched under Australia's SAS-B pathway, targeting large underserved markets in women's and men's health. The company’s capital-light, partner-led model aims for rapid revenue growth post-ARTG registration.